Biofrontera Inc.
Clinical trials sponsored by Biofrontera Inc., explained in plain language.
-
New light therapy could zap stubborn acne
Disease control OngoingThis study tests a light-based treatment called photodynamic therapy (PDT) using a special gel (Ameluz®) and a lamp (BF-RhodoLED®) for adults with moderate to severe acne. About 126 participants will receive either the active treatment or a placebo gel to see if it safely reduces…
Phase: PHASE2 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New light therapy shows promise for skin cancer treatment
Disease control OngoingThis study tests a gel called Ameluz® combined with a special red light to treat a common type of skin cancer called superficial basal cell carcinoma. About 187 adults with at least one skin cancer spot will receive either the active gel or a placebo before light treatment. The g…
Phase: PHASE3 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New light therapy gel shows promise for common skin condition
Disease control OngoingThis study tests a gel (Ameluz®) combined with red light therapy to treat actinic keratosis, a common precancerous skin condition caused by sun damage. About 172 adults with 4 to 15 spots on their arms, legs, neck, or trunk will receive either the active gel or a placebo gel befo…
Phase: PHASE3 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC